Hansen Medical, Inc., a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 40th Annual VEITHsymposium from November 19th-23rd at the Hilton New York in New York City. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 201.
Multiple presentations and physician panel sessions discussing the growing body of compelling clinical data on the Magellan Robotic System will also be conducted at the conference. In addition, Hansen Medical will be co-sponsoring a symposium with Philips Healthcare at noon on Wednesday, November 20th, titled "Clinical Excellence in the Hybrid OR." Professor Jean-Pierre Becquemin, M.D. from Henri Mondor Hospital, Cretéil, France will moderate this session and share his clinical experiences with the Magellan Robotic System in complex abdominal aortic aneurysm (AAA) repair procedures. Additionally, Hansen Medical will be the sole sponsor of a symposium at noon on Thursday, November 21st, titled "Clinical Experiences with the Magellan Robotic System." Five speakers (Jean Bismuth, M.D., Methodist Hospital, Houston; Barry Katzen, M.D., Baptist Cardiac & Vascular Institute, Miami; Thomas Nolte, M.D., Bad Bevensen in Germany; Professor Nabil Chakfé, M.D., Hospital Civil Strasbourg in France; and Professor Nicholas Cheshire, M.D., St. Mary's Hospital, London) will discuss their clinical experiences with the Magellan System in a wide variety of endovascular procedure types.
Hansen Medical also anticipates that the Magellan System will be featured in the following scheduled presentations:
Summary of Experience with the Hansen Magellan System for Robotic Assisted Complex and Routine Endovascular Procedures: Advantages and Limitations, by Professor Cheshire; Thursday, November 21st at 2:07 p.m. Clinical Experience with Vascular Robotics (Hansen) In EVAR, Carotid and Other Vascular Applications, by Dr. Katzen; Thursday, November 21st at 2:12 p.m.
"The VEITHsymposium is one of the year's most important vascular conferences and we are pleased to have our Magellan System highlighted prominently in numerous settings throughout the conference," said Bruce Barclay, President and CEO of Hansen Medical. "The high level of activity around intravascular robotics at this meeting is a strong reflection of the continuing momentum we are seeing both clinically and commercially with the Magellan System."